Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02172586Phase 4Completed
A Phase 4 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Jan 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02172586.